MedPath
TGA Approval

OTEZLA apremilast 30 mg film coated tablet blister pack (220423)

220423

OTEZLA apremilast 30 mg film coated tablet blister pack

Amgen Australia Pty Ltd

March 19, 2015

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-CMI-01863-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-PI-01522-1

Active Ingredients

apremilast

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

OTEZLA apremilast 30 mg film coated tablet blister pack (220423) - TGA 批准文号 | MedPath